AKR1B1 and breast cancer: In basal-like breast cancer, an aggressive triple-negative subtype of mammary cancer, AKR1B1 is transcriptionally activated by Twist2 and sustains a positive feedback loop involving NF-κB activation via PGF2A, thereby reinforcing EMT and enhancing tumor invasiveness.